C07C 311/07
Having the nitrogen atom of at least one of the sulfonamide groups
Official title: having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
C07C311/07 (Having the nitrogen atom of at least one of the sulfonamide groups) appears on 88 US grants and 104 published applications in this corpus.
Search patents in C07C- Granted patents
- 88
- Published applications
- 104
- Assignees
- 65
- Inventors
- 354
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 4 | 0 |
| 2002 | 1 | 5 |
| 2003 | 4 | 3 |
| 2004 | 2 | 9 |
| 2005 | 6 | 4 |
| 2006 | 3 | 2 |
| 2007 | 1 | 3 |
| 2008 | 3 | 2 |
| 2009 | 1 | 2 |
| 2010 | 2 | 9 |
| 2011 | 0 | 4 |
| 2012 | 4 | 8 |
| 2013 | 5 | 5 |
| 2014 | 6 | 6 |
| 2015 | 6 | 2 |
| 2016 | 4 | 4 |
| 2017 | 3 | 3 |
| 2018 | 2 | 6 |
| 2019 | 3 | 4 |
| 2020 | 2 | 5 |
| 2021 | 2 | 1 |
| 2022 | 0 | 5 |
| 2023 | 1 | 1 |
| 2024 | 2 | 8 |
| 2025 | 6 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Process for the production of ozanimod4 Nov 2025US 12,459,907 B2Egis Gyogyszergyar Zrt.
- Inhibitors of the Wnt/beta-catenin pathway2 Sep 2025US 12,404,243 B2The Regents of the University of California
- Potassium channel inhibitors19 Aug 2025US 12,391,644 B2Saniona A/S
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-1715 Jul 2025US 12,358,866 B2Reata Pharmaceuticals Holdings, LLC
- Cyclic diones as herbicidal compounds3 Jun 2025US 12,319,640 B2Syngenta Crop Protection AG
- Cyclopentane compound7 May 2026US 2026/0124201 A1Kissei Pharmaceutical Co., Ltd.
- Novel potassium channel inhibitors19 Feb 2026US 2026/0049054 A1Saniona A/S
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-1720 Nov 2025US 2025/0353813 A1Reata Pharmaceuticals Holdings, LLC
- Cyclohexyl beta-hydroxy alkyl amines and medical uses thereof28 Nov 2024US 2024/0390298 A1Atrogi AB
- Novel potassium channel inhibitors7 Nov 2024US 2024/0368077 A1Saniona A/S
Most cited
By later US patents
- Npyy5 antagonists74US 6,699,891 B1Shionogi & Co., Ltd. · 2004
- Amino-benzocycloalkane derivatives63US 6,197,798 B1Novartis AG · 2001
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-1750US 8,124,799 B2Reata Pharmaceuticals, Inc. · 2012
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at C-1745US 8,440,854 B2Reata Pharmaceuticals, Inc. · 2013
- Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-1730US 9,102,681 B2Reata Pharmaceuticals, Inc. · 2015